verapamil has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (29.63) | 18.7374 |
| 1990's | 15 (55.56) | 18.2507 |
| 2000's | 3 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Chiyotani, A; Isono, K; Kondo, M; Konno, K; Sakai, N; Tamaoki, J | 1 |
| Haught, WH; Lawson, DL; Mehta, JL; Yang, BC | 1 |
| Taira, N; Yamagishi, T; Yanagisawa, T | 1 |
| Gill, JR; Keiser, H; Ohman, KP; Yun, JC | 1 |
| Bevan, J; Heptinstall, S | 1 |
| Escalante, B; Reyes, JL | 1 |
| Kane, KA; Kwan, YW; Wadsworth, RM | 1 |
| Akopov, SE; Gabrielyan, ES; Khashimov, KA; Orekhov, AN; Smirnov, VN; Tertov, VV | 1 |
| Iwanov, V; Moulds, RF; Young, MS | 1 |
| Cunard, CM; Maddox, YT; Ramwell, PW | 1 |
| Horwitz, PM; Kadowitz, PJ; Landry, AZ; Lippton, HL; McNamara, DB | 1 |
| Giessler, C; Mentz, P; Pawelski, KE | 1 |
| Izawa, T; Izumi, H; Kasai, H; Ogawa, N; Okada, Y; Yokoyama, T | 1 |
| Han, SZ; Karaki, H; Orimo, H; Ouchi, Y; Stergiopoulos, K; Tabata, RE | 1 |
| Iwamoto, T; Morita, T; Nishimura, N; Sukamoto, T | 1 |
| Aljada, A; Dandona, P; Khurana, U; Love, J; Mousa, S; Thusu, K | 1 |
| Abe, A; Hori, M; Karaki, H; Kinoshita, M; Mitsui-Saito, M; Ozaki, H; Uehigashi, Y | 1 |
| Paul, RJ; Rapoport, RM; Tosun, M | 3 |
| He, GW | 1 |
| Chan, NW; Huang, Y; Kwok, KH; Lau, CW | 1 |
| He, GW; Yang, CQ | 1 |
| Diener, M; Frings, M; Haschke, G; Heinke, B; Schäfer, KH | 1 |
| Hori, M; Karaki, H; Ozaki, H; Tasaki, K; Wakabayashi, I | 1 |
| Honjo, H; Ito, S; Kamiya, K; Kume, H; Makino, Y; Oguma, T; Shimokata, K; Shiraki, A | 1 |
| Fujisawa, M; Ito, D; Murai, C; Murata, A; Nakagome, Y; Obara, K; Oikawa, S; Ou, G; Saitoh, N; Shimizu, M; Tanaka, Y; Xu, K; Yamashita, M; Yoshioka, K | 1 |
27 other study(ies) available for verapamil and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Thromboxane A2 mimetic U46619 stimulates ciliary motility of rabbit tracheal epithelial cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Cilia; Cyclic AMP; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; Fatty Acids, Unsaturated; Hydrazines; Isoproterenol; Isoquinolines; Male; Movement; Piperazines; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Rabbits; Thromboxane A2; Trachea; Verapamil | 1992 |
Slow channel calcium blockers attenuate reoxygenation-mediated vascular contraction, but augment anoxia-mediated vascular contraction.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Aorta; Diltiazem; In Vitro Techniques; Indomethacin; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Oxygen; Oxyhemoglobins; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Thromboxane A2; Vasoconstriction; Verapamil | 1992 |
Ca2+ influx induced by the agonist U46619 is inhibited by hyperpolarization induced by the K+ channel opener cromakalim in canine coronary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Benzopyrans; Calcium; Coronary Vessels; Cromakalim; Dogs; Dose-Response Relationship, Drug; Female; Fluorescence; In Vitro Techniques; Male; Potassium Channels; Prostaglandin Endoperoxides, Synthetic; Pyrroles; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 1992 |
Effects of prostaglandins, cAMP, and changes in cytosolic calcium on platelet aggregation induced by a thromboxane A2 mimic (U46619).
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Bucladesine; Calcium; Calcium Channel Blockers; Colforsin; Cyclic AMP; Cytosol; Egtazic Acid; Female; Gallic Acid; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Thromboxane A2; Verapamil | 1991 |
How can we inhibit 5-HT-induced platelet aggregation and why should we bother?
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Amlodipine; Female; Humans; Male; Middle Aged; Nifedipine; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Serotonin Antagonists; Verapamil | 1988 |
Intracellular mechanisms of the effect of thromboxane A2 on water transport.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Body Water; Calcium; Cell Line; Colchicine; Kidney; Kinetics; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Trifluoperazine; Verapamil | 1989 |
Effects of hypoxia on the pharmacological responsiveness of isolated coronary artery rings from the sheep.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Coronary Vessels; Hypoxia; In Vitro Techniques; Indomethacin; Muscle Contraction; Muscle, Smooth, Vascular; Oxygen Consumption; Phentolamine; Potassium Chloride; Propranolol; Prostaglandin Endoperoxides, Synthetic; Serotonin; Sheep; Verapamil | 1989 |
Stable analogues of prostacyclin and thromboxane A2 display contradictory influences on atherosclerotic properties of cells cultured from human aorta. The effect of calcium antagonists.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aorta; Arteriosclerosis; Cells, Cultured; Diltiazem; DNA Replication; Epoprostenol; Humans; Muscle, Smooth, Vascular; Prostaglandin Endoperoxides, Synthetic; Prostaglandins, Synthetic; Verapamil | 1988 |
Interaction between platelet-released serotonin and thromboxane A2 on human digital arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arteries; Blood Platelets; Calcium; Drug Synergism; Humans; In Vitro Techniques; Nifedipine; Prostaglandin Endoperoxides, Synthetic; Serotonin; Thromboxane A2; Verapamil | 1986 |
Endothelium-dependent gender differences in the response of the rat pulmonary artery to the thromboxane mimic (U46619).
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Endothelium; Female; Male; Muscle, Smooth, Vascular; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Rats; Sex Factors; Vasoconstriction; Verapamil | 1986 |
Influence of verapamil and diltiazem on aggregatory responses in cat and rabbit platelet rich plasma.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Animals; Arachidonic Acid; Arachidonic Acids; Benzazepines; Calcium Channel Blockers; Cats; Diltiazem; Female; In Vitro Techniques; Male; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Rabbits; Verapamil | 1984 |
Drug induced inhibition of the cardiac effects of U 46619 as a thromboxane A2-like agonist.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Pressure; Cardiovascular Agents; Dipyridamole; Guinea Pigs; Heart; Heart Atria; Myocardial Contraction; Propranolol; Prostaglandin Endoperoxides, Synthetic; Trapidil; Verapamil | 1984 |
Effect of Kil769, a novel K(+)-channel opener, on sensitivity to Ca2+ of contractile elements and inositol phosphate formation in porcine coronary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium; Calcium Channel Blockers; Coronary Vessels; Dose-Response Relationship, Drug; Fura-2; Glyburide; Hydrolysis; In Vitro Techniques; Inositol Phosphates; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Potassium Channels; Prostaglandin Endoperoxides, Synthetic; Pyridines; Swine; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 1995 |
Calcium channel blocking substances for prevention of atherosclerosis.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arteriosclerosis; Calcium; Calcium Channel Blockers; Diet, Atherogenic; Estradiol; Magnesium; Male; Myocardial Contraction; Prostaglandin Endoperoxides, Synthetic; Rabbits; Rats; Rats, Wistar; Swine; Thromboxane A2; Verapamil | 1995 |
Differential vasorelaxant effects of K(+)-channel openers and Ca(2+)-channel blockers on canine isolated arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arteries; Benzopyrans; Calcium Channel Blockers; Cromakalim; Dogs; Female; Guanidines; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Pinacidil; Piperazines; Potassium Channels; Prostaglandin Endoperoxides, Synthetic; Pyrroles; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Verapamil | 1993 |
Calcium, calmodulin and protein kinase C dependence of platelet shape change.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Binding Sites; Blood Platelets; Calcium; Calcium Channel Blockers; Calmodulin; Cell Size; Chelating Agents; Edetic Acid; Gallic Acid; Humans; Intracellular Fluid; Mesylates; Peptides, Cyclic; Platelet Activation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Thromboxane A2; Vasoconstrictor Agents; Verapamil | 1996 |
Effects of a prostaglandin I2 analog iloprost on cytoplasmic Ca2+ levels and muscle contraction in isolated guinea pig aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta; Calcium; Cyclic AMP; Dinoprost; Dose-Response Relationship, Drug; Guinea Pigs; Iloprost; In Vitro Techniques; Indomethacin; Male; Muscle, Smooth, Vascular; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Vasoconstriction; Verapamil | 1996 |
Role of extracellular Ca++ influx via L-type and non-L-type Ca++ channels in thromboxane A2 receptor-mediated contraction in rat aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta; Calcium; Calcium Channels; Calcium Channels, L-Type; Male; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Vasoconstriction; Verapamil | 1998 |
Intracellular Ca2+ elevation and contraction due to prostaglandin F2alpha in rat aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta, Thoracic; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Calcium Channel Blockers; Calcium Channels; Dinoprost; Fatty Acids, Unsaturated; Hydrazines; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Thromboxane A2; Verapamil | 1997 |
Coupling of store-operated Ca++ entry to contraction in rat aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta; Calcium; Hydroquinones; Indoles; Male; Nickel; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Rats, Sprague-Dawley; Vasoconstriction; Verapamil | 1998 |
Verapamil plus nitroglycerin solution maximally preserves endothelial function of the radial artery: comparison with papaverine solution.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Calcimycin; Coronary Artery Bypass; Drug Combinations; Endothelium, Vascular; Humans; In Vitro Techniques; Ionophores; Nitroglycerin; Papaverine; Radial Artery; Safety; Specimen Handling; Tissue Preservation; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Verapamil | 1998 |
Contractile and relaxant effects of tetrapentylammonium ions in rat isolated mesenteric artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium Channel Blockers; Endothelin-1; Endothelium, Vascular; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nifedipine; Phenylephrine; Potassium; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Verapamil | 1998 |
Comparison of the vasorelaxant effect of nitroprusside and nitroglycerin in the human radial artery in vitro.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Drug Interactions; Endothelin-1; Humans; In Vitro Techniques; Nitroglycerin; Nitroprusside; Potassium; Radial Artery; Vasodilation; Vasodilator Agents; Verapamil | 1999 |
Spontaneous contractions of intestinal smooth muscle re-aggregates from the new-born rat triggered by thromboxane A2.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Animals, Newborn; Calcium; Carbachol; Carbazoles; Cell Aggregation; Cholinergic Agonists; Fluorescent Dyes; Fura-2; Intestine, Small; Microscopy, Fluorescence; Muscle Contraction; Muscle, Smooth; Platelet Aggregation Inhibitors; Rats; Sulfonamides; Tetrodotoxin; Thromboxane A2; Vasoconstrictor Agents; Verapamil | 2000 |
Difference in signal transduction mechanisms involved in 5-hydroxytryptamine- and U46619-induced vasoconstrictions.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta; Calcium; Enzyme Inhibitors; Extracellular Fluid; Genistein; Imidazoles; Male; Naphthalenes; Pyridines; Rats; Rats, Wistar; Serotonin; Signal Transduction; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 2003 |
Role of Ca2+ mobilization and Ca2+ sensitization in 8-iso-PGF 2 alpha-induced contraction in airway smooth muscle.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amides; Animals; Bridged-Ring Compounds; Calcium Channel Blockers; Calcium Signaling; Diltiazem; Dinoprost; Dioxanes; Enzyme Inhibitors; Estrenes; Guinea Pigs; Imidazoles; In Vitro Techniques; Indoles; Male; Maleimides; Muscle Contraction; Muscle, Smooth; Norbornanes; Pyridines; Pyrrolidinones; Receptors, Thromboxane A2, Prostaglandin H2; rho-Associated Kinases; Signal Transduction; Thiocarbamates; Thiones; Trachea; Type C Phospholipases; Vasoconstrictor Agents; Verapamil | 2009 |
Docosahexaenoic acid and eicosapentaenoic acid strongly inhibit prostanoid TP receptor-dependent contractions of guinea pig gastric fundus smooth muscle.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium Channels, L-Type; Docosahexaenoic Acids; Eicosapentaenoic Acid; Gastric Fundus; Guinea Pigs; Muscle, Smooth; Prostaglandins; Receptors, Thromboxane; RNA, Messenger; Verapamil | 2022 |